Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade A 28.21 1.99% 0.55
HZNP closed up 1.99 percent on Tuesday, March 19, 2019, on 65 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical HZNP trend table...

Date Alert Name Type % Chg
Mar 19 Spinning Top Other 0.00%
Mar 19 Outside Day Range Expansion 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Overbought Stochastic Strength 0.00%
Mar 18 Stochastic Reached Overbought Strength 1.99%
Mar 18 Wide Bands Range Expansion 1.99%
Mar 18 Overbought Stochastic Strength 1.99%
Mar 15 Wide Bands Range Expansion 1.15%
Mar 15 Up 3 Days in a Row Strength 1.15%
Mar 15 Up 4 Days in a Row Strength 1.15%

Older signals for HZNP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Asthma Osteoarthritis Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology Psoriatic Arthritis
Is HZNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.44
52 Week Low 12.55
Average Volume 2,120,891
200-Day Moving Average 20.1107
50-Day Moving Average 23.4182
20-Day Moving Average 25.473
10-Day Moving Average 26.94
Average True Range 1.2213
ADX 26.52
+DI 33.8548
-DI 17.2862
Chandelier Exit (Long, 3 ATRs ) 25.7761
Chandelier Exit (Short, 3 ATRs ) 23.7139
Upper Bollinger Band 31.2045
Lower Bollinger Band 19.7415
Percent B (%b) 0.74
BandWidth 45.000589
MACD Line 1.4114
MACD Signal Line 1.2936
MACD Histogram 0.1178
Fundamentals Value
Market Cap 4.61 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -10.45
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.37
Resistance 3 (R3) 30.31 29.53 30.01
Resistance 2 (R2) 29.53 28.98 29.56 29.89
Resistance 1 (R1) 28.87 28.64 29.20 28.93 29.77
Pivot Point 28.09 28.09 28.26 28.12 28.09
Support 1 (S1) 27.43 27.54 27.76 27.49 26.65
Support 2 (S2) 26.65 27.20 26.68 26.53
Support 3 (S3) 25.99 26.65 26.41
Support 4 (S4) 26.05